Use of AliveCor ECG Monitoring to Replicate ECG Lead Recording

Not Applicable

Withdrawn

• Conditions: Arrhythmia

• Registration Number: NCT04472520
• Lead Sponsor: Mayo Clinic

Brief Summary

The researchers are trying to determine whether the Alivecor device can simulate other electrocardiogram (ECG) leads to record electrical activity.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-06-05
• Status Verified: 2020-07
• Study First Submitted QC: 2020-07-10
• Last Update Submitted: 2020-07-10
• Study First Posted: 2020-07-15
• Last Update Posted: 2020-07-15
• Study Start: 2021-01-01
• Primary Completion: 2021-12-31
• Study Completion: 2022-12-31

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Individuals greater than 18 years old getting an ECG

Exclusion Criteria

• Patients unwilling or unable to provide informed consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Electrocardiogram (ECG) QT Interval	1 day	The QT interval represents the time of ventricular activity including both depolarization and repolarization. It is measured from the beginning of the QRS complex to the end of the T wave. Normally, the QT interval is 0.36 to 0.44 seconds

Trial Locations

Locations (1)

Mayo Clinic Arizona; 🇺🇸 Phoenix, Arizona, United States